Neslihan Coban
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Neslihan Coban has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Nihan Erginel-Unaltuna
Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey
10 shared publications - Aybike Sena Ozuynuk
Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey
8 shared publications - Aycan Fahri Erkan
Department of Cardiology, Faculty of Medicine, Ufuk University, Ankara, Turkey
7 shared publications Berkay Ekici
Ufuk University, Faculty of Medicine, Department of Cardiology, Ankara, Turkey, 06520
7 shared publicationsAycan Fahri Erkan
Ufuk Univ, Fac Med, Dept Cardiol, Ankara, Turkiye
6 shared publications- Berkay Ekici
Department of Cardiology, Faculty of Medicine, Ufuk University, Ankara, Turkey
6 shared publications
Latest Publications
- 19 June 2026
- Published by Springer Nature in Molecular Genetics and Genomics
- Vol. 301 (1) , 144
Genotype-dependent metabolic and inflammatory regulation at the ANRIL locus in human primary macrophages
The long non-coding RNA ANRIL and several single-nucleotide polymorphisms have been strongly implicated in genetic susceptibility to coronary artery disease (CAD). However, how these variants influence gene expression remains incompletely understood. This study aims to investigate genotype-dependent differences in linear and circular ANRIL isoform expression and selected CAD- and diabetes-related genes in monocyte-derived macrophages from healthy adult males carrying rs1333049, rs10757274, and rs564398 variants. Peripheral blood monocytes from healthy male donors with specific ANRIL genotypes were isolated and differentiated into macrophages using macrophage colony-stimulating factor. Monocyte identity and macrophage differentiation were confirmed by flow cytometry and confocal imaging. Gene expression levels of CDKN2A, CDKN2B, ABCA1, PRKAA1, PPARGC1A, TNFA, TNFAIP3, and circular and linear ANRIL transcripts were quantified by qRT-PCR. Expression differences across genotype groups and genotype-dependent correlations were assessed. The rs10757274/rs1333049 AA/CC genotype was associated with reduced expression of PPARGC1A and ABCA1, accompanied by lower TNFA and higher TNFAIP3 expression. In contrast, carriage of the G allele at rs10757274/rs1333049 was associated with increased expression of CDKN2A and linear ANRIL. The rs564398 CC genotype was associated with reduced PPARGC1A expression and altered PRKAA1 levels. Correlation analyses revealed genotype-specific associations between ANRIL isoforms and selected genes. These findings suggest that ANRIL variants are associated with genotype-dependent differences in macrophage gene expression across pathways of cell cycle regulation, inflammation, lipid metabolism, and energy homeostasis. Although exploratory, the results support the possibility that CAD- and diabetes-associated 9p21.3 variants may partly exert their effects through such transcriptional alterations. Graphical abstract The alternative text for this image may have been generated using AI.
- 19 June 2026
- Published by Springer Nature in Molecular Genetics and Genomics
- Vol. 301 (1) , 144
Genotype-dependent metabolic and inflammatory regulation at the ANRIL locus in human primary macrophages
The long non-coding RNA ANRIL and several single-nucleotide polymorphisms have been strongly implicated in genetic susceptibility to coronary artery disease (CAD). However, how these variants influence gene expression remains incompletely understood. This study aims to investigate genotype-dependent differences in linear and circular ANRIL isoform expression and selected CAD- and diabetes-related genes in monocyte-derived macrophages from healthy adult males carrying rs1333049, rs10757274, and rs564398 variants. Peripheral blood monocytes from healthy male donors with specific ANRIL genotypes were isolated and differentiated into macrophages using macrophage colony-stimulating factor. Monocyte identity and macrophage differentiation were confirmed by flow cytometry and confocal imaging. Gene expression levels of CDKN2A, CDKN2B, ABCA1, PRKAA1, PPARGC1A, TNFA, TNFAIP3, and circular and linear ANRIL transcripts were quantified by qRT-PCR. Expression differences across genotype groups and genotype-dependent correlations were assessed. The rs10757274/rs1333049 AA/CC genotype was associated with reduced expression of PPARGC1A and ABCA1, accompanied by lower TNFA and higher TNFAIP3 expression. In contrast, carriage of the G allele at rs10757274/rs1333049 was associated with increased expression of CDKN2A and linear ANRIL. The rs564398 CC genotype was associated with reduced PPARGC1A expression and altered PRKAA1 levels. Correlation analyses revealed genotype-specific associations between ANRIL isoforms and selected genes. These findings suggest that ANRIL variants are associated with genotype-dependent differences in macrophage gene expression across pathways of cell cycle regulation, inflammation, lipid metabolism, and energy homeostasis. Although exploratory, the results support the possibility that CAD- and diabetes-associated 9p21.3 variants may partly exert their effects through such transcriptional alterations. Graphical abstract The alternative text for this image may have been generated using AI.
- 26 May 2026
- Published by Elsevier in Tissue and Cell
- Vol. 102, 103633
Examining the effect of Angiopoietin-like protein 8 (ANGPTL8) on mitochondrial quality and atherosclerosis in vitro
- 26 May 2026
- Published by Elsevier in Tissue and Cell
- Vol. 102, 103633
Examining the effect of Angiopoietin-like protein 8 (ANGPTL8) on mitochondrial quality and atherosclerosis in vitro
- 9 October 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 248, 108415
Evaluation of gene and microRNA expression patterns in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as rare diseases
- 9 October 2025
- Published by Elsevier in Respiratory Medicine
- Vol. 248, 108415
Evaluation of gene and microRNA expression patterns in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as rare diseases
- Open Access
- 4 December 2023
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 55 (3) , 361-372
Alteration of circulating miRNAs during myocardial infarction and association with lipid levels
Background: Increasing mortality and morbidity of coronary artery disease (CAD) highlight the emerging need for novel noninvasive markers such as circulating microRNAs (miRNAs). Objective: To evaluate the circulating levels of miR-126-3p, miR-210-3p, let-7g-5p, and miR-326, and their associations with known contributors to CAD, in CAD subgroups. Methods: We divided the cohort into 4 groups: non-CAD controls (≤30% stenosis; n = 55), and patients with stable angina pectoris (SAP; n = 48), unstable AP (UAP; n = 46), and myocardial infarction (MI; n = 36). The circulating levels of miR-126-3p, miR-210-3p, let-7g-5p, and miR-326 were determined using TaqMan Advanced miRNA Assays in serum specimens. Results: Circulating miR-126-3p levels were lower in the MI and UAP groups, compared with the non-CAD group, whereas miR-210-3p circulating levels were lower in the MI group than others. The levels of circulating let-7g-5p were shown to be useful for distinguishing UAP from MI, and there were substantial differences in circulating let-7g-5p levels between the UAP and MI groups. Moreover, lipid levels and ratios were lower in individuals with high circulating miR-126-3p and miR-210-3p levels. Conclusions: The study results suggest that circulating miR-126-3p, miR-210-3p, and let-7g-5p are differentiated between different clinical presentations of CAD and associated with lipid levels, which are important risk factors and determinants of CAD.
- 4 December 2023
- Published by Oxford University Press (OUP) in Laboratory Medicine
- Vol. 55 (3) , 361-372
Open AccessAlteration of circulating miRNAs during myocardial infarction and association with lipid levels
Background: Increasing mortality and morbidity of coronary artery disease (CAD) highlight the emerging need for novel noninvasive markers such as circulating microRNAs (miRNAs). Objective: To evaluate the circulating levels of miR-126-3p, miR-210-3p, let-7g-5p, and miR-326, and their associations with known contributors to CAD, in CAD subgroups. Methods: We divided the cohort into 4 groups: non-CAD controls (≤30% stenosis; n = 55), and patients with stable angina pectoris (SAP; n = 48), unstable AP (UAP; n = 46), and myocardial infarction (MI; n = 36). The circulating levels of miR-126-3p, miR-210-3p, let-7g-5p, and miR-326 were determined using TaqMan Advanced miRNA Assays in serum specimens. Results: Circulating miR-126-3p levels were lower in the MI and UAP groups, compared with the non-CAD group, whereas miR-210-3p circulating levels were lower in the MI group than others. The levels of circulating let-7g-5p were shown to be useful for distinguishing UAP from MI, and there were substantial differences in circulating let-7g-5p levels between the UAP and MI groups. Moreover, lipid levels and ratios were lower in individuals with high circulating miR-126-3p and miR-210-3p levels. Conclusions: The study results suggest that circulating miR-126-3p, miR-210-3p, and let-7g-5p are differentiated between different clinical presentations of CAD and associated with lipid levels, which are important risk factors and determinants of CAD.
- 28 June 2023
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 78 (8) , 945-956
Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease
MicroRNAs have been found to have an essential role in cardiovascular diseases. In previous experiments, the changed expressions of miR-26a-5p and miR-19a-3p were confirmed in patients with severe coronary atherosclerosis by miRNA microarrays. However, the role of two miRNAs in coronary artery diseases (CAD) still needs to be investigated further. Our current study aimed to analyse two miRNAs in angiographically confirmed CAD and non-CAD with insignificant coronary stenosis. This study aimed to identify the potential diagnostic value of circulating miRNA with CAD. The CAD patients (n = 50) and non-CAD controls (n = 43) were studied. miRNAs (miR-26a-5p and miR-19a-3p) were quantified by TaqMan miRNA assays using real-time PCR. We subsequently assessed the diagnostic value of the miRNAs and correlations of miRNA with clinical parameters. Target prediction tools were utilised to identify miRNA target genes. The expression of miR-26a-5p was significantly increased in CAD compared to non-CAD controls (p < 0.05). Tertile groups were formed according to the expression levels of miRNAs, and high expression tertile (T3) was compared with low expression tertile (T1). It was found that CAD presence was more prevalent in T3 of miR-26a-5p, and the frequency of diabetes was higher in T3 of miR-19a-3p. There were significant correlations between miRNAs and diabetes risk factors such as HbA1c, glucose levels, and BMI (p < 0.05). Our findings show that miR-26a-5p expression is altered in CAD presence while miR-19a-3p expression is different in diabetes. Both miRNAs are closely related to risk factors of CAD, therefore, could be therapeutic targets for CAD treatment.
- 28 June 2023
- Published by Taylor & Francis in Acta Cardiologica
- Vol. 78 (8) , 945-956
Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease
MicroRNAs have been found to have an essential role in cardiovascular diseases. In previous experiments, the changed expressions of miR-26a-5p and miR-19a-3p were confirmed in patients with severe coronary atherosclerosis by miRNA microarrays. However, the role of two miRNAs in coronary artery diseases (CAD) still needs to be investigated further. Our current study aimed to analyse two miRNAs in angiographically confirmed CAD and non-CAD with insignificant coronary stenosis. This study aimed to identify the potential diagnostic value of circulating miRNA with CAD. The CAD patients (n = 50) and non-CAD controls (n = 43) were studied. miRNAs (miR-26a-5p and miR-19a-3p) were quantified by TaqMan miRNA assays using real-time PCR. We subsequently assessed the diagnostic value of the miRNAs and correlations of miRNA with clinical parameters. Target prediction tools were utilised to identify miRNA target genes. The expression of miR-26a-5p was significantly increased in CAD compared to non-CAD controls (p < 0.05). Tertile groups were formed according to the expression levels of miRNAs, and high expression tertile (T3) was compared with low expression tertile (T1). It was found that CAD presence was more prevalent in T3 of miR-26a-5p, and the frequency of diabetes was higher in T3 of miR-19a-3p. There were significant correlations between miRNAs and diabetes risk factors such as HbA1c, glucose levels, and BMI (p < 0.05). Our findings show that miR-26a-5p expression is altered in CAD presence while miR-19a-3p expression is different in diabetes. Both miRNAs are closely related to risk factors of CAD, therefore, could be therapeutic targets for CAD treatment.
- 5 April 2023
- Published by Springer Nature in Biochemical Genetics
- Vol. 61 (6) , 2276-2292
Association of Intelectin 1 Gene rs2274907 A > T Polymorphism with Obesity, Type 2 Diabetes, Serum Intelectin-1 Levels and Lipid Profiles in Turkish Adults
The anti-inflammatory adipokine intelectin-1, which is encoded by the ITLN1 gene, is hypothesized to be linked to the pathogenesis of type 2 diabetes (T2DM) and obesity. The purpose of this study was to examine the effect of the ITLN1 gene polymorphism rs2274907 on obesity and T2DM in Turkish adults. The impact of genotype on lipid profiles and serum intelectin levels in the obese and diabetes groups was also investigated. Randomly selected 2266 adults (mean age, 55.0 ± 11.7 years; 51.2% women) participating in the population-based Turkish adult risk factor study were cross-sectionally analyzed. The genotyping of rs2274907 A > T polymorphism was performed by using the hybridization probe based LightSNiP assay in real-time PCR. T2DM were defined using the criteria of the American Diabetes Association. Obesity was described as Body mass index ≥ 30 kg/m2. Statistical analyses were used to investigate the association of genotypes with clinical and biochemical measurements. According to findings, there was no vital connection between the rs2274907 polymorphism and obesity, T2DM, or serum intelectin-1 level. The TA+AA carriers had significantly higher triglyceride levels (p = 0.007) compared with the TT carriers in both obese and T2DM women when adjusted for relevant covariates. ITLN1 rs2274907 polymorphism is not correlated with the risk of obesity and T2DM and not affect serum ITLN1 levels in Turkish adults. However, this polymorphism appears to be important in regulating triglyceride levels in obese and diabetic women.
- 5 April 2023
- Published by Springer Nature in Biochemical Genetics
- Vol. 61 (6) , 2276-2292
Association of Intelectin 1 Gene rs2274907 A > T Polymorphism with Obesity, Type 2 Diabetes, Serum Intelectin-1 Levels and Lipid Profiles in Turkish Adults
The anti-inflammatory adipokine intelectin-1, which is encoded by the ITLN1 gene, is hypothesized to be linked to the pathogenesis of type 2 diabetes (T2DM) and obesity. The purpose of this study was to examine the effect of the ITLN1 gene polymorphism rs2274907 on obesity and T2DM in Turkish adults. The impact of genotype on lipid profiles and serum intelectin levels in the obese and diabetes groups was also investigated. Randomly selected 2266 adults (mean age, 55.0 ± 11.7 years; 51.2% women) participating in the population-based Turkish adult risk factor study were cross-sectionally analyzed. The genotyping of rs2274907 A > T polymorphism was performed by using the hybridization probe based LightSNiP assay in real-time PCR. T2DM were defined using the criteria of the American Diabetes Association. Obesity was described as Body mass index ≥ 30 kg/m2. Statistical analyses were used to investigate the association of genotypes with clinical and biochemical measurements. According to findings, there was no vital connection between the rs2274907 polymorphism and obesity, T2DM, or serum intelectin-1 level. The TA+AA carriers had significantly higher triglyceride levels (p = 0.007) compared with the TT carriers in both obese and T2DM women when adjusted for relevant covariates. ITLN1 rs2274907 polymorphism is not correlated with the risk of obesity and T2DM and not affect serum ITLN1 levels in Turkish adults. However, this polymorphism appears to be important in regulating triglyceride levels in obese and diabetic women.
- 2 July 2022
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 727, 109340
Identification of the pathogenic effects of missense variants causing PRKAG2 cardiomyopathy
- 2 July 2022
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 727, 109340
Identification of the pathogenic effects of missense variants causing PRKAG2 cardiomyopathy